Join
Live feed
·
INSIDERFilingvia Quantisnow
Avenue Therapeutics Inc. logo

Interim PFO and COO Jin David was granted 65,000 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ATXI· Avenue Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ATXI (Avenue Therapeutics Inc.) and more on Quantisnow.

Interim PFO and COO Jin David was granted 65,000 shares (SEC Form 4) | Quantisnow